Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
4
CHENGUANG MEDICAL
430300
5
TLC
873576
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -21.54%203.43M | -17.30%49.5M | -21.81%48.28M | -21.19%52.1M | -25.18%53.55M | -19.36%259.28M | -19.15%59.86M | -20.56%61.75M | -16.62%66.11M | -20.90%71.57M |
Operating revenue | -21.54%203.43M | -17.30%49.5M | -21.81%48.28M | -21.19%52.1M | -25.18%53.55M | -19.36%259.28M | -19.15%59.86M | -20.56%61.75M | -16.62%66.11M | -20.90%71.57M |
Cost of revenue | -22.84%94.08M | -13.69%23.56M | -20.47%22.68M | -24.41%24.04M | -30.62%23.81M | -26.94%121.92M | -30.45%27.3M | -27.93%28.52M | -21.14%31.8M | -28.13%34.31M |
Gross profit | -20.39%109.35M | -20.33%25.94M | -22.96%25.6M | -18.20%28.06M | -20.17%29.74M | -11.18%137.36M | -6.41%32.56M | -12.92%33.23M | -11.93%34.31M | -12.83%37.26M |
Operating expense | -23.59%131.9M | -15.38%34.28M | -13.37%32.35M | -20.22%35M | -40.54%30.27M | -41.61%172.62M | -35.90%40.51M | -38.51%37.34M | -46.32%43.87M | -43.44%50.91M |
Selling and administrative expenses | -27.39%113.44M | -17.43%29.68M | -18.41%27.55M | -25.75%29.56M | -42.93%26.65M | -42.80%156.22M | -38.67%35.95M | -38.58%33.76M | -47.47%39.82M | -44.25%46.69M |
-Selling and marketing expense | -51.79%10.27M | -24.28%2.95M | -30.58%2.82M | -47.63%2.44M | -76.33%2.05M | -67.87%21.29M | -43.56%3.9M | -53.14%4.06M | -73.98%4.66M | -73.55%8.67M |
-General and administrative expense | -23.53%103.17M | -16.60%26.73M | -16.74%24.73M | -22.85%27.12M | -35.31%24.59M | -34.77%134.93M | -38.01%32.05M | -35.85%29.7M | -39.27%35.16M | -25.41%38.02M |
Research and development costs | 12.53%18.46M | 0.81%4.59M | 34.21%4.8M | 34.16%5.44M | -13.99%3.63M | -27.12%16.4M | -0.46%4.56M | -37.94%3.58M | -31.58%4.05M | -32.44%4.22M |
Operating profit | 36.06%-22.55M | -4.90%-8.33M | -64.34%-6.75M | 27.45%-6.94M | 96.10%-533K | 74.99%-35.26M | 72.03%-7.94M | 81.80%-4.11M | 77.64%-9.56M | 71.11%-13.66M |
Net non-operating interest income expense | 20.53%-12.78M | 61.79%-1.59M | 29.02%-2.94M | -1.81%-4.12M | -10.73%-4.13M | -66.00%-16.08M | -50.31%-4.16M | -62.80%-4.15M | -76.98%-4.04M | -78.68%-3.73M |
Non-operating interest expense | -20.53%12.78M | -61.79%1.59M | -29.02%2.94M | 1.81%4.12M | 10.73%4.13M | 66.00%16.08M | 50.31%4.16M | 62.80%4.15M | 76.98%4.04M | 78.68%3.73M |
Other net income (expense) | -2.52%7.94M | -202.97%-2.71M | 638.16%8.36M | -63.54%1M | -70.38%1.28M | -87.07%8.15M | -85.80%2.63M | -104.74%-1.55M | -71.77%2.75M | 117.12%4.33M |
Gain on sale of security | 4,477.78%9.89M | 23.45%1.87M | 385.88%7.81M | -99.54%8K | 167.81%198K | -99.70%216K | -97.76%1.51M | -197.50%-2.73M | 46.36%1.73M | ---292K |
Special income (charges) | ---5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Other special charges | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -61.45%3.06M | -61.37%430K | -53.35%550K | -2.64%994K | -76.54%1.08M | 305.33%7.93M | -36.44%1.11M | -0.51%1.18M | 111.62%1.02M | 131.78%4.62M |
Income before tax | 36.60%-27.38M | -33.26%-12.63M | 86.49%-1.33M | 7.42%-10.05M | 74.11%-3.38M | 50.73%-43.19M | 25.18%-9.48M | -227.79%-9.8M | 69.25%-10.86M | 72.43%-13.06M |
Income tax | 5.26%40K | -10.00%9K | 57.14%11K | -9.09%10K | 0.00%10K | -29.63%38K | -47.37%10K | -30.00%7K | 450.00%11K | -56.52%10K |
Net income | 36.57%-27.42M | -33.21%-12.64M | 86.38%-1.34M | 7.42%-10.06M | 74.05%-3.39M | 50.71%-43.23M | 25.21%-9.49M | -228.05%-9.81M | 69.22%-10.87M | 72.42%-13.07M |
Net income continuous Operations | 36.57%-27.42M | -33.21%-12.64M | 86.38%-1.34M | 7.42%-10.06M | 74.05%-3.39M | 50.71%-43.23M | 25.21%-9.49M | -228.05%-9.81M | 69.22%-10.87M | 72.42%-13.07M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 36.57%-27.42M | -33.21%-12.64M | 86.38%-1.34M | 7.42%-10.06M | 74.05%-3.39M | 50.71%-43.23M | 25.21%-9.49M | -228.05%-9.81M | 69.22%-10.87M | 72.42%-13.07M |
Preferred stock dividends | -28.66%849K | -66.16%375K | 112.20%174K | 150K | 150K | 1.19M | 1.11M | 82K | ||
Other preferred stock dividends | 0 | 976K | ||||||||
Net income attributable to common stockholders | 36.36%-28.27M | -35.28%-13.01M | 86.11%-1.51M | 6.04%-10.21M | 72.91%-3.54M | 49.36%-44.42M | 24.17%-9.62M | -241.86%-10.87M | 69.22%-10.87M | 72.42%-13.07M |
Basic earnings per share | 40.63%-0.76 | -25.93%-0.34 | 87.10%-0.04 | 12.50%-0.28 | 74.36%-0.1 | 73.61%-1.28 | 32.50%-0.27 | -224.00%-0.31 | 93.95%-0.32 | 73.20%-0.39 |
Diluted earnings per share | 40.63%-0.76 | -25.93%-0.34 | 87.10%-0.04 | 12.50%-0.28 | 74.36%-0.1 | 73.61%-1.28 | 32.50%-0.27 | -234.78%-0.31 | 93.95%-0.32 | 73.20%-0.39 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |